Soren Germer, PhD
Senior Vice President, Genome Technologies, NYGCSoren Germer, PhD, leads the sequencing operations at the New York Genome Center (NYGC), overseeing production sequencing, technology development, project management, and clinical diagnostics. He was appointed to this position in January 2019.
Dr. Germer joined NYGC in March of 2012 as a Sequencing Program Manager and was involved in establishing operations at NYGC at multiple levels, subsequently serving as Senior Scientific Director, Sequencing Operations. Prior to NYGC, he was a translational research scientist at Roche Pharmaceuticals, where he led a next-generation sequencing lab supporting pre-clinical and early development programs in the areas of virology, oncology, immunology and metabolic diseases. He began his career at Roche Molecular Diagnostics, where he focused on developing new techniques for SNP genotyping and applying them to complex disease research.
Prior ExperienceDr. Germer attended the University of Copenhagen, and received his PhD from the University of California at Berkeley.